ALE.F02 (RENAL-F02)

· Alentis Therapeutics AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALE.F02 (RENAL-F02), covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Rescue of Nephrons With ALE.F02 (RENAL-F02) [Phase 2]